The healthy side of bananas: The underrated fruit

According to Japanese Scientific Research, full ripe banana with dark patches on yellow skin produces a substance called TNF (Tumor Necrosis Factor) which has the ability to combat abnormal cells. The more darker patches it has the higher will be its immunity enhancement quality; Hence, the riper the banana the better the anti-cancer quality.
Yellow skin banana with dark spots on it is 8x more effective in enhancing the property of white blood cells than green skin version.

We knew bananas were good for you but this we didn’t know.

The fully ripe banana produces a substance called TNF, which has the ability to combat abnormal cells.

As the banana ripens, it develops dark spots or patches on the skin. The more dark patches it has, the higher will be its’ immunity enhancement quality.

Hence, the Japanese love bananas for a good reason…

According to a Japanese scientific research, banana contains TNF, which has anti-cancer properties.

The degree of anti-cancer effect corresponds to the degree of ripeness of the fruit, i.e. the riper the banana, the better the anti-cancer quality…

In an animal experiment carried out by a professor in Tokyo U comparing the various health benefits of different fruits, using banana, grape, apple, water melon, pineapple, pear and persimmon, it was found that banana gave the best results. It increased the number of white blood cells, enhanced the immunity of the body and produced anti-cancer substance TNF.

The recommendation is to eat 1 to 2 bananas a day to increase your body immunity to diseases like cold, flu and others.

According to the Japanese professor, yellow skin bananas with dark spots on it are 8 times more effective in enhancing the property of white blood cells than the green skin version. 

Molecule in immune system 'may help fight skin cancer'

   

Researchers, including one of Indian origin, have found that high expression of a cell-signalling molecule, known as interleukin-9, in immune cells inhibits melanoma growth.

After observing mice without genes responsible for development of an immune cell called T helper cell 17 (TH17), the researchers from Brigham and Women’s Hospital (BWH) found that these mice had significant resistance to melanoma tumour growth, suggesting that blockade of the TH17 cell pathway favoured tumour inhibition. The researchers also noticed that the mice expressed high amounts of interleukin-9.

"These were unexpected results, which led us to examine a possible contribution of interleukin-9 to cancer growth suppression.” Rahul Purwar said.

The researchers next treated melanoma-bearing mice with T helper cell 9 (TH9), an immune cell that produces interleukin-9. They saw that these mice also had a profound resistance to melanoma growth. This is the first reported finding showing an anti-tumour effect of TH9 cells.

Moreover, the researchers were able to detect TH9 cells in both normal human blood and skin, specifically in skin-resident memory T cells and memory T cells in peripheral blood mononuclear cells. In contrast, TH9 cells were either absent or present at very low levels in human melanoma. This new finding paves the way for future studies that will assess the role of interleukin-9 and TH9 cells in human cancer therapy.

Melanoma is the most dangerous form of skin cancer. It is curable if recognized and treated early. The study has been published online in Nature Medicine.